Paxlovid cuts Covid death risk. But those who need it are not taking it.

The medicine is stunningly effective in preventing severe illness and death.

View in browser|nytimes.com Continue reading the main story January 9, 2024 Paxlovid cuts the risk of death by 73 percent for high-risk Covid patients, according to a National Institutes of Health study. Wolfgang Rattay/Reuters So why aren't more people taking it? → Sign up for Science Times Get stories that capture the wonders of nature, the cosmos and the human body. Get it in your inbox Continue reading the main story ADVERTISEMENT Continue reading the main story Need help? Review our newsletter help page or contact us for assistance. You received this message because you signed up for updates from The New York Times. To stop receiving From The Times, unsubscribe. To opt out of other promotional emails from The Times, including those regarding The Athletic, manage your email settings. To opt out of updates and offers sent from The Athletic, submit a request. Subscribe to The TimesGet The New York Times app Connect with us on: Change Your EmailPrivacy PolicyContact UsCalifornia Notices The New York Times Company. 620 Eighth Avenue New York, NY 10018